Join the DDA or

Pregabalin/gabapentin become S3 CDs but no cabinet requirement

January 9th 2019

Tagged: Dispensary guidance news

From Monday 1 April, pregabalin and gabapentin will be classified as Schedule 3 Controlled Drugs (CDs) following amendments to the Misuse of Drugs Regulations 2001 and the Safe Custody Regulations 1973.

Pregabalin and gabapentin will be subject to the prescription writing requirements for Schedule 3 CDs but they are exempt from the safe custody regulations which means that they do not need to be kept in the CDs cabinet.

This follows Government consultation and recommendations from the Advisory Council on the Misuse of Drugs for additional safeguards to be put in place because of concerns around the misuse of these drugs.

For more information, please visit the government’s website and the UK legislation website.

For all the latest news of the 2019 DDA annual conference...

Learn more